Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 784 across all filing types
Latest filing 2021-12-31 Proxy Solicitation & In…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
NOTICE OF THE EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for PW Medtech Group Limited. It includes details about the meeting date, location, agenda items such as approval of a share transfer agreement and re-election of a director, and procedural notes for shareholders. There is no financial data, audit information, or report content. The document is clearly a meeting notice rather than a report or announcement of voting results. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2021-12-31 English
MAJOR AND CONNECTED TRANSACTION - ACQUISITION OF 51% EQUITY INTEREST IN THE TARGET COMPANY AND PROPOSED RE-ELECTION OF A DIRECTOR AND NOTICE OF EGM
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular issued by PW Medtech Group Limited regarding a major and connected transaction involving the acquisition of 51% equity interest in a target company. It includes detailed information such as letters from the Board, Independent Board Committee, Independent Financial Adviser, financial information, accountants' report, management discussion and analysis, pro forma financial information, general information, details of director re-election, and notice of an Extraordinary General Meeting (EGM). The document is comprehensive and lengthy (15,000 characters), containing substantive financial and transaction details, not merely an announcement or notice. It is not a full annual or interim report but rather a transaction circular related to a major acquisition and related shareholder meeting. This type of document is best classified under Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to solicit their votes on the transaction and director re-election at the EGM.
2021-12-31 English
DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding a delay in the despatch of a circular related to an acquisition transaction. It references a previous announcement and states that the circular, which contains details of the Share Transfer Agreement and notice of an Extraordinary General Meeting (EGM), will be postponed. The document is short (1838 characters) and serves as a notification about the timing of a report (the circular) rather than the report itself. There is no financial data or detailed report content included. Therefore, this document is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2021-12-21 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2021
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities, specifically focusing on authorized and issued shares, share options, and confirmations related to securities issued by PW Medtech Group Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content is regulatory in nature, reporting share capital and share issuance movements for the month ended 30 November 2021. It does not contain financial statements, management discussion, or earnings data, nor is it an announcement of a report publication. It is a regulatory filing reporting share capital movements and confirmations, fitting the category of Regulatory Filings (RNS).
2021-12-06 English
MAJOR AND CONNECTED TRANSACTION - ACQUISITION OF 51% EQUITY INTEREST IN THE TARGET COMPANY
M&A Activity Classification · 95% confidence The document is an announcement by PW Medtech Group Limited regarding a major and connected transaction involving the acquisition of 51% equity interest in a target company. It details the share transfer agreement, consideration, price adjustment mechanism, closing conditions, termination rights, and information on the parties involved. The announcement references compliance with listing rules, shareholder approval requirements, and an upcoming extraordinary general meeting (EGM) for approval. The content is focused on a merger/acquisition transaction and does not contain financial statements or detailed financial performance data. It is not a full annual or interim report, nor an earnings release or regulatory filing. The document is a formal announcement of a major transaction and related shareholder meeting, fitting the category of M&A Activity (TAR).
2021-11-30 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2021
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 October 2021. It details movements in authorized and issued share capital, share options, and confirmations related to securities issued by the issuer. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance movements for a specific month. It does not contain financial statements, earnings data, or management discussion. It is a regulatory filing reporting share capital movements and confirmations, fitting the category of Regulatory Filings (RNS).
2021-11-04 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.